On September 4, 2025, Palisade Bio, Inc. approved a Phantom Unit Plan allowing up to 10,000,000 phantom units tied to stock value for employees, with specific grants for executives including 323,400 units for CEO J.D. Finley, and other key officers receiving substantial awards; this plan mandates no ownership rights and is effective for ten years.